Tuesday, February 12, 2013

• Vanda Pharmaceuticals' CEO Discusses Q4 2012 Results - Earnings Call Transcriptat Seeking Alpha (Tue, Feb 12)
• Earnings roundup: Huntsman, Marsh & McLennanAP (Tue, Feb 12)
• Vanda takes bigger loss on sleep drug developmentAP (Tue, Feb 12)
• Vanda Pharmaceuticals Inc. Earnings Call scheduled for 10:00 am ET todayCCBN (Tue, Feb 12)
• VANDA PHARMACEUTICALS INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements anEDGAR Online (Tue, Feb 12)
• Vanda Pharmaceuticals Reports Fourth Quarter 2012 and Full Year 2012 ResultsPR Newswire (Tue, Feb 12)

Monday, February 4, 2013

• This Week in Biotechat Motley Fool (Mon, Feb 4)

Friday, February 1, 2013

• Vanda Drug Fails in Depression Studyat Motley Fool (Fri, Feb 1)

Thursday, January 31, 2013

• 4 Healthcare Stock Stories for Thursday Wellnessat Wall St. Cheat Sheet (Thu, Jan 31)
• Vanda Pharmaceuticals Inc Conference Call to Discuss Top-Line Results of Phase IIb/III Clinical Study (MAGELLAN) in Major Depressive Disorder scheduled for 9:00 am ET todayCCBN (Thu, Jan 31)
• VANDA PHARMACEUTICALS INC. Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online (Thu, Jan 31)
• Vanda Announces Phase IIb/III Clinical Study In Major Depressive Disorder Did Not Meet The Primary EndpointPR Newswire (Thu, Jan 31)

Saturday, January 26, 2013

• This Week in Biotech: Part 1at Motley Fool (Sat, Jan 26)

Friday, January 25, 2013

• As The Cash Burn At Vanda Pharmaceuticals Intensifies, All Eyes Are Now On The FDAat Seeking Alpha (Fri, Jan 25)

Thursday, January 24, 2013

• 4 Healthcare Stock Stories Prescribed for Investorsat Wall St. Cheat Sheet (Thu, Jan 24)

Wednesday, January 23, 2013

• Healthcare Recap: Earnings, Drug Trials, and Liquidationat Wall St. Cheat Sheet (Wed, Jan 23)
• Vanda says sleep drug met goal in clinical trialAP (Wed, Jan 23)
• Vanda Announces Positive Results in the Second Phase III Study of Tasimelteon for the Treatment of Non-24-Hour Disorder -Conference Call scheduled for 9:00 am ET todayCCBN (Wed, Jan 23)
• Vanda announces positive results in second Phase III study of Tasimelteonat theflyonthewall.com (Wed, Jan 23)
• VANDA PHARMACEUTICALS INC. Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online (Wed, Jan 23)

Wednesday, December 26, 2012

• VANDA PHARMACEUTICALS INC. Files SEC form 8-K, Change in Directors or Principal OfficersEDGAR Online (Wed, Dec 26)

Tuesday, December 25, 2012

• Three Odd Quant Stories: Odd Stocks, Network Connections and Insider Buyingat Forbes (Tue, Dec 25)

Wednesday, December 19, 2012

• Stock Watch Wednesday, 19 Decemberat Seeking Alpha (Wed, Dec 19)
• Four Companies That Stuck Out on Tuesday; and that Might Trade Higherat Motley Fool (Wed, Dec 19)

Tuesday, December 18, 2012

• Pfizer Slashes Sales Jobs, Merck & GE Affiliate Collaborate: Healthcare Business Updateat Wall St. Cheat Sheet (Tue, Dec 18)

Add VNDA News to My Yahoo!